Eyebot Raises $20 Million to Revolutionize Vision Care Access with Rapid, Doctor-Verified Testing
[City, state] – August 29, 2024 – Eyebot, the innovative company disrupting the vision care industry with its cutting-edge 90-second vision test kiosks, today announced the successful completion of a $20 million Series A funding round. Led by General Catalyst, with significant participation from returning investors AlleyCorp, Baukunst, Village Global, and Ubiquity Ventures, this investment signals strong confidence in Eyebot’s mission to make accessible, affordable, and high-quality vision care a reality for millions.
For decades, accessing vision care has been plagued by frustrating barriers: lengthy appointment wait times, complex insurance processes, and geographical limitations. Eyebot is dismantling these obstacles, offering a streamlined, convenient, and clinically sound choice. Their network of kiosks,strategically located in high-traffic areas like malls,universities,retail stores,and grocery chains,provides a free vision test that culminates in a valid glasses prescription – all within 90 seconds. Crucially,every prescription is meticulously reviewed and verified by a team of licensed eye doctors,ensuring accuracy and patient safety.
Addressing a Critical Need in US Vision Care
The need for accessible vision care is significant. According to the National Eye Institute,over 3 million Americans live with vision impairment,and an additional 8 million suffer from uncorrected refractive errors like nearsightedness.Many delay or forgo necessary eye exams due to prohibitive costs, inconvenient scheduling, or a simple lack of nearby providers.this delay can have significant consequences, impacting everything from academic performance and workplace productivity to overall quality of life.
“We founded Eyebot because we believe clear vision shouldn’t be a privilege, but a right,” explains Matthias Hofmann, co-founder and CEO of Eyebot. “This funding isn’t just about expansion; it’s about fundamentally changing how people think about and access vision care. We’re removing the friction points that have historically prevented millions from getting the eye health services they need.”
Beyond Convenience: A Clinically Rigorous approach
Eyebot isn’t simply offering a faster way to get a prescription; they’re pioneering a new model of care built on a foundation of clinical rigor. The company has completed over 2,500 Institutional Review board (IRB)-approved patient studies, demonstrating that its technology achieves accuracy comparable to customary, in-person eye exams. Moreover, patient satisfaction scores for Eyebot-generated prescriptions consistently surpass industry averages.
This commitment to quality is further reinforced by Eyebot’s Clinical Advisory Board, chaired by Chief Medical Officer Dr. Alexander Martin. comprised of leading experts in both optometry and ophthalmology, the board provides crucial guidance on clinical oversight and ensures the company maintains the highest standards of care as it expands.
“Eyebot isn’t replacing eye doctors; it’s empowering them,” emphasizes Dr. Martin. “We’re providing a valuable tool that extends their reach, allowing them to serve more patients and address the growing vision care gap. Our doctor-led approach ensures that accessibility doesn’t come at the expense of quality or safety.”
What’s Next for Eyebot?
The $20 million in Series A funding will fuel several key initiatives:
Nationwide Expansion: Eyebot plans to rapidly expand its kiosk network to hundreds of new retail locations across the country, bringing convenient vision testing to a wider audience.
Team growth: The company will considerably scale its clinical and engineering teams to support its ambitious growth plans and continue innovating its technology.
Strategic Partnerships: Eyebot will deepen its engagement with eye care professionals, fostering collaboration and integration with existing practices. Several high-profile launches with leading retail partners are planned for later this year, promising to accelerate nationwide adoption.
A Win-Win for Patients, Retailers, and Eye Care Professionals
Eyebot’s innovative model offers benefits across the board. Patients gain access to affordable, convenient, and doctor-verified vision care. Retailers can expand their service offerings with a minimal footprint and attract new customers. And eye care professionals can leverage Eyebot’s technology to increase their capacity and reach a broader patient base.
Eyebot is not just changing how people get their vision checked; it’s changing who has access to vision care.By removing barriers and embracing innovation, Eyebot is poised to redefine the future of eye health in the United States.
*About Eyebot
Keep reading